Trial
NCT04372641
Testing the Safety of CB-5339 in Patients With Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Aggressive Non-Hodgkin Lymphoma
Intervention
p97 Inhibitor CB-5339 Tosylate
Why stopped
Other - Clinical development of the agent has been discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-17